Archive


Category: $39B

  • AstraZeneca to Acquire Alexion for $39B

    Shots: Alexion to receive $60M in cash and 2.1243 ADSs (each ADS represents ½ ordinary share of AstraZeneca) for each Alexion share. The deal values Alexion at $175/ share with a 45% premium to the closing price on Dec 11, 2020 Alexion will own ~15% of the combined company. The acquisition will bolster AstraZeneca’s footprints […]